Aiken S P, Horn N M, Saunders N R
Du Pont Merck Pharmaceutical Company, Wilmington, DE.
Biometals. 1992 Winter;5(4):235-43. doi: 10.1007/BF01061224.
Histidine has been reported to affect body zinc status by increasing urinary zinc excretion. The effects of experimental histidinemia on distribution of 65Zn in anesthetized rats were studied. Infusion of L-histidine at a rate sufficient to raise plasma concentrations to approximately 2 mM for 6 h starting 48 h after a single intraperitoneal 65Zn injection did not alter 65Zn activities in a variety of tissues when compared with anesthetized uninfused animals. However, plasma 65Zn and erythrocyte 65Zn were decreased, and liver 65Zn was increased. If 65Zn was injected intravenously during histidine infusion, net accumulation of zinc by some tissues was increased, but uptake by others was reduced relative to uninfused animals. In all cases, however, uptake expressed relative to plasma 65Zn levels was increased when allowance was made for the more rapid fall in plasma 65Zn during histidine infusion. Similar infusions of D-histidine produced quantitatively similar effects. Since enzymatic mechanisms and amino acid carriers would be expected to show stereoselectivity, such processes are unlikely to be involved in the zinc distribution changes described. The possibility of zinc transport by a hitherto unidentified carrier is discussed. These experiments confirm that histidinemia can affect zinc status, but any associated changes in urinary zinc excretion do not seem adequate to account for the tissue changes found.
据报道,组氨酸会通过增加尿锌排泄来影响机体锌状态。研究了实验性组氨酸血症对麻醉大鼠体内65Zn分布的影响。在单次腹腔注射65Zn 48小时后,以足以使血浆浓度升高至约2 mM的速率输注L-组氨酸6小时,与未输注的麻醉动物相比,多种组织中的65Zn活性没有改变。然而,血浆65Zn和红细胞65Zn减少,肝脏65Zn增加。如果在输注组氨酸期间静脉注射65Zn,相对于未输注的动物,一些组织对锌的净积累增加,但其他组织的摄取减少。然而,在所有情况下,当考虑到输注组氨酸期间血浆65Zn下降更快时,相对于血浆65Zn水平的摄取增加。输注D-组氨酸产生了定量相似的效果。由于酶促机制和氨基酸载体预计会表现出立体选择性,因此这些过程不太可能参与所述的锌分布变化。讨论了由迄今未鉴定的载体转运锌的可能性。这些实验证实组氨酸血症会影响锌状态,但尿锌排泄的任何相关变化似乎都不足以解释所发现的组织变化。